[go: up one dir, main page]

WO2013176538A3 - Tenogenic medium for mesenchymal stem cells differentation into tenogenic lineage - Google Patents

Tenogenic medium for mesenchymal stem cells differentation into tenogenic lineage Download PDF

Info

Publication number
WO2013176538A3
WO2013176538A3 PCT/MY2013/000108 MY2013000108W WO2013176538A3 WO 2013176538 A3 WO2013176538 A3 WO 2013176538A3 MY 2013000108 W MY2013000108 W MY 2013000108W WO 2013176538 A3 WO2013176538 A3 WO 2013176538A3
Authority
WO
WIPO (PCT)
Prior art keywords
tenogenic
mesenchymal stem
stem cells
lineage
mscs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/MY2013/000108
Other languages
French (fr)
Other versions
WO2013176538A2 (en
Inventor
Tunku Kamarul Zaman Tunku Zainol Abidin MADYA
Sik Loo TAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universiti Malaya
Original Assignee
Universiti Malaya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiti Malaya filed Critical Universiti Malaya
Publication of WO2013176538A2 publication Critical patent/WO2013176538A2/en
Publication of WO2013176538A3 publication Critical patent/WO2013176538A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/066—Tenocytes; Tendons, Ligaments
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/19—Growth and differentiation factors [GDF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Rehabilitation Therapy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Tenocytes are highly differentiated cells which have a limited potential for replication. Therefore, in vitro propagation of tenocytes may still not be able to supply enough seed cells for tendon tissue engineering. Bone marrow mesenchymal stem cells (MSCs) are able to self-renew and capable to differentiate into multi lineage including tenocytes. Therefore, it is possible that MSCs could serve as seed cells in tendon tissue engineering. In the present invention, method and culture medium for promoting human bone marrow mesenchymal stem cells (MSCs) differentiation into tenogenic lineage is provided.
PCT/MY2013/000108 2012-05-22 2013-06-13 Tenogenic medium for mesenchymal stem cells differentation into tenogenic lineage Ceased WO2013176538A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI2012002249 2012-05-22
MYPI2012002249 2012-05-22

Publications (2)

Publication Number Publication Date
WO2013176538A2 WO2013176538A2 (en) 2013-11-28
WO2013176538A3 true WO2013176538A3 (en) 2014-03-06

Family

ID=49624465

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MY2013/000108 Ceased WO2013176538A2 (en) 2012-05-22 2013-06-13 Tenogenic medium for mesenchymal stem cells differentation into tenogenic lineage

Country Status (1)

Country Link
WO (1) WO2013176538A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110295140A (en) * 2019-06-04 2019-10-01 河北贝特赛奥生物科技有限公司 A kind of method of free serum culture mesenchymal stem cell
EP3872168A1 (en) 2020-02-28 2021-09-01 Cline Scientific AB Chondrocyte differentiation
WO2024000073A1 (en) * 2022-06-30 2024-01-04 Stemcell Technologies Canada Inc. Media, kits and methods for differentiating tenocytes or chondrocytes
CN120586169B (en) * 2025-08-08 2025-11-18 四川大学华西医院 BME-SIS biological film and preparation method and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012013969A1 (en) * 2010-07-26 2012-02-02 The University Of Manchester Targeted differentiation of stem cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012013969A1 (en) * 2010-07-26 2012-02-02 The University Of Manchester Targeted differentiation of stem cells

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
MAZZOCCA, AUGUSTUS D. ET AL.: "Bone marrow-derived mesenchymal stem cells obtained during arthroscopic rotator cuff repair surgery show potential for tendon cell differentiation after treatment with insulin", ARTHROSCOPY: THE JOURNAL OF ARTHROSCOPIC & RELATED SURGERY, vol. 27, no. 11, 2011, pages 1459 - 1471 *
PARK, ANDREW ET AL.: "Adipose-derived mesenchymal stem cells treated with growth differentiation factor-5 express tendon-specific markers", TISSUE ENGINEERING, vol. 16, no. 9, 2010, pages 2941 - 2951 *
TAN, SIK-LOO ET AL.: "Effect of growth differentiation factor 5 on the proliferation and tenogenic differentiation potential of human mesenchymal stem cells in vitro", CELLS TISSUES ORGANS, vol. 196, no. 4, 30 May 2012 (2012-05-30), pages 325 - 338 *
WANG, XIAOLI ET AL.: "Characterization of mesenchymal stem cells isolated from mouse fetal bone marrow", STEM CELLS, vol. 24, 2006, pages 482 - 493 *
ZHANG, JIANYING ET AL.: "Platelet-rich plasma releasate promotes differentiation of tendon stem cells into active tenocytes", THE AMERICAN JOURNAL OF SPORTS MEDICINE, vol. 38, no. 12, 2010, pages 2477 - 2486 *

Also Published As

Publication number Publication date
WO2013176538A2 (en) 2013-11-28

Similar Documents

Publication Publication Date Title
Gaspar et al. Progress in cell-based therapies for tendon repair
MX2017004890A (en) Methods and compositions for generating or maintaining pluripotent cells.
WO2011139628A8 (en) Generation of anterior foregut endoderm from pluripotent cells
PH12014501175A1 (en) Medium composition for rejuvenating stem cells
IN2014MN01680A (en)
WO2009134532A3 (en) Homing in mesenchymal stem cells
WO2011149762A3 (en) Method of nociceptor differentiation of human embryonic stem cells and uses thereof
MX358451B (en) Methods for purifying cells derived from pluripotent stem cells.
WO2013070881A8 (en) Method for elimination of space through tissue approximation
MY183058A (en) Production method for retinal tissue
MY151979A (en) Method for producing mesenchymal stem cells from human pluripotent stem cells, and mesenchymal stem cells produced by same
GB2485112A (en) Differentiation of human embryonic stem cells
EP2504425A4 (en) DIFFERENTIATION OF HUMAN EMBRYONIC AND INDUCED PLURIPOTENTER STEM CELLS
EP4534650A3 (en) Differentiation of human ips cells to human alveolar type ii via definitive endoderm
WO2012092049A8 (en) Brown adipocyte modification
WO2011160055A3 (en) Hair follicle neogenesis
BR112014027783A2 (en) differentiation of human embryonic stem cells into pancreatic endoderm
MX2015007361A (en) Acp-mediated production of fatty acid derivatives.
WO2011043629A3 (en) Method of inducing high activity of human adipose stem cell and medium therefor
BR112015009229A2 (en) composition targeting gene expression for platelets, hematopoietic stem cell, use of said stem cell and in vitro or ex vivo method for generating a modified stem cell
AR099557A1 (en) FGF-18 IN TRANSFERS OF TREATMENT ENGINEERING AND PROCEDURES
EP2596097A4 (en) BONE MARROW MESENCHYMAL STEM CELLS WITH HIGH TELOMERASE ACTIVITY, METHODS FOR PRODUCING THE SAME, AND PHARMACEUTICAL PRODUCTS AND METHODS OF TREATMENT BASED ON THESE CELLS
NZ703345A (en) Compositions and methods for reducing frequency and/or severity of headache
WO2012075462A3 (en) Methods and compositions for treatment of muscular dystrophy
WO2014204806A3 (en) Adipose cells for chondrocyte applications

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13793201

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13793201

Country of ref document: EP

Kind code of ref document: A2